The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
RedHill announced the UK MHRA has approved the Company’s CTA application to commence a study evaluating opaganib in patients hospitalized with severe ...
read more
The FDA and EC have paved the way for a multitude of critical collaborations on many scientific and regulatory fronts as part of our COVID-19 response...
read more
The FDA approved Fintepla for the treatment of seizures associated with Dravet syndrome in patients age 2 and older.
read more
Supernus has sued generic drug maker Apotex Inc. and Apotex Corp. for infringement of nine patents covering its antiepileptic drug Oxtellar XR.
read more
Cytocom announced the successful completion of a meeting with the FDA in relation to the Company's trial of CYTO-201 for the treatment of SARS-CoV-2.
read more
The FDA granted accelerated approval to selinexor for adult patients with relapsed or refractory diffuse large B-cell lymphoma.
read more
Linnaeus announced an agreement with Merck to evaluate LNS8801 and KEYTRUDA in patients with selected advanced solid tumors.
read more
IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans.
read more
NeuroRx and Relief announced the FDA awarded Fast Track Designation for Aviptadil for acute lung injury/acute respiratory distress syndrome associated...
read more
Fulcrum has received early notification from the FDA that the company may proceed with a trial of losmapimod in higher risk hospitalized adults with ...
read more
BrainStorm Cell Therapeutics announced a new clinical program focused on the development of NurOwn as a treatment for Alzheimer's disease.
read more
The FDA approved pembrolizumab for patients with recurrent or metastatic cutaneous squamous cell carcinoma.
read more
Seelos announced the initiation of a preclinical study of SLS-007 in Parkinson's disease delivered through an adeno associated viral vector targeting ...
read more
EMD Millipore Corporation
EMD Serono announced the FDA has cleared its IND for M5049 for the treatment of patients with Covid-19 pneumonia.
read more
Allergan announced the FDA has accepted the company's sBLA to expand BOTOX for symptoms of detrusor overactivity associated with an underlying ...
read more